In order to explore the molecular mechanisms predicting the therapeutic effects of the drugs on BC targeting, molecular docking experiments of the key drugs disulfiram and eugenol with the pivotal genes ACADS, AIFM2, GSR, and PMAIP1 were performed in this study. Here, PMAIP1 is linked to breast cancer.